Stephen P. Cary, Ph.D.
Affiliations: | 2005 | University of Michigan, Ann Arbor, Ann Arbor, MI |
Area:
catalytic and biological properties of redox enzymesGoogle:
"Stephen Cary"Mean distance: 8.3 | S | N | B | C | P |
Parents
Sign in to add mentor| Michael A. Marletta | grad student | 2005 | University of Michigan | |
| (Tonic and acute nitric oxide signaling through soluble guanylate cyclase: Roles of non-heme nitric oxide, ATP, and globins.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Boehme J, Le Moan N, Kameny RJ, et al. (2019) Correction: Preservation of myocardial contractility during acute hypoxia with OMX-CV, a novel oxygen delivery biotherapeutic. Plos Biology. 17: e3000119 |
| Boehme J, Le Moan N, Kameny RJ, et al. (2018) Preservation of myocardial contractility during acute hypoxia with OMX-CV, a novel oxygen delivery biotherapeutic. Plos Biology. 16: e2005924 |
| Moan NL, Leung P, Ng S, et al. (2018) Abstract 4726A: The oxygen carrier omx restores antitumor immunity and cures tumors as a single agent or in combination with checkpoint inhibitors in an intracranial glioblastoma mouse model Cancer Research. 78 |
| Leong KG, Pan Y, Guo C, et al. (2018) Abstract 1744: Reversal of advanced colitis-associated colon cancer by OMX, a novel oxygen carrier that immunosensitizes the hypoxic tumor microenvironment Immunology. 78: 1744-1744 |
| Le Moan N, Davis T, Leung P, et al. (2018) TMIC-15. OMX IS A TUMOR MICROENVIRONMENT MODIFIER THAT RESTORES ANTI-TUMOR IMMUNITY AND IMPROVES ANTI-TUMOR EFFICACY BY REDUCING TUMOR HYPOXIA IN INTRACRANIAL GLIOBLASTOMA MOUSE MODEL Neuro-Oncology. 20: vi259-vi259 |
| Moan NL, Leung P, Ng S, et al. (2017) Abstract 4686: Omx a hypoxia modulator reverses the immunosuppressive glioblastoma microenvironment by stimulating T cell infiltration and activation that results in increased number of long-term survivors Cancer Research. 77: 4686-4686 |
| Leong KG, Pan Y, Winger JA, et al. (2017) Abstract 1627: Enhancement of anti-cancer immunity by OMX, a novel oxygen carrier immunotherapeutic that ameliorates the hypoxic tumor microenvironment Cancer Research. 77: 1627-1627 |
| Leong KG, Moan NL, Pan Y, et al. (2016) Abstract B029: OMX: An oxygen carrier biotherapeutic that ameliorates the hypoxic tumor microenvironment and promotes anticancer T cell activity Cancer Immunology Research. 4 |
| Krtolica A, Moan NL, Leung P, et al. (2016) Abstract 2790: Sensitizing the hypoxic tumor microenvironment with OMX, a breakthrough oxygen delivery protein: From protein engineering to clinical trial Cancer Research. 76: 2790-2790 |
| Moan NL, Leung P, Bedard C, et al. (2016) IMST-52. OMX, AN IND-STAGE BROAD-ACTING OXYGEN CARRIER, IMMUNOSENSITIZES THE TUMOR MICROENVIRONMENT AND PROMOTES EFFECTOR T CELL RESPONSES IN THE GL261 INTRACRANIAL SYNGENEIC GLIOBLASTOMA MODEL Neuro-Oncology. 18: vi98-vi98 |